Form 8-K - Current report:
SEC Accession No. 0001401914-20-000124
Filing Date
2020-12-07
Accepted
2020-12-07 08:09:06
Documents
2
Period of Report
2020-12-07
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dare8-k12072020bv.htm 8-K 43847
2 EX-99.1 ex991120720.htm EX-99.1 33896
  Complete submission text file 0001401914-20-000124.txt   79082
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 201371399
SIC: 2834 Pharmaceutical Preparations